Our Expertise

Pharmaceutical, biopharmaceutical, CDMO, and CMO companies face growing pressures to deliver more products at a lower cost while ensuring the quality and security of supply. Advanced PAT technologies address these challenges by increasing scalable product through more consistent quality, higher yields, and greater throughput. In addition, digitalization advances such as extensive connectivity, increased computing power, and advanced analytics have all continued to strengthen the accessibility and power of PAT to accelerate market growth.

Continua’s Team is Knowledgeable About and Experienced With:

• The latest advances in PAT that enable significant gains in quality, profitability and sustainability
• Ways to greatly reduce production delays, waste, rework and compliance failures
• Innovative approaches to drive end-to-end production—from the active pharmaceutical ingredient to the finished pharmaceutical product